Singapore
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 95.90 M
|
June 30, 2024 | USD 10.41 | 0.13% |
|
Singapore |
|
2 |
USD 0.00
|
Dec. 31, 2023 | USD 3.55 | -1.66% |
|
Singapore |
|
3 |
USD -1.11 M
|
Dec. 31, 2023 | USD 11.57 | -4.06% |
|
Singapore |
|
4 |
USD -2.14 M
|
Dec. 31, 2023 | USD 2.64 | 1.93% |
|
Singapore |
The Healthcare company in Singapore with the highest Net Cash Used For Investing Activities is Prestige BioPharma Limited (KSE: 950210.KS) at USD 95.90 M.
The Healthcare company in Singapore with the lowest Net Cash Used For Investing Activities is CytoMed Therapeutics Limited (NasdaqCM: GDTC) at USD -2.14 M.
The top 10 Healthcare companies in Singapore by Net Cash Used For Investing Activities are Prestige BioPharma Limited, EUDA Health Holdings Limited, Wave Life Sciences Ltd. and CytoMed Therapeutics Limited.
The bottom 10 Healthcare companies in Singapore by Net Cash Used For Investing Activities are CytoMed Therapeutics Limited, Wave Life Sciences Ltd., EUDA Health Holdings Limited and Prestige BioPharma Limited.